Bioprojet products
ANAPEN - Auto-Injector Pen
Auto-injector pen for the immediate treatment of anaphylactic shock
TIORFAN - Racecadotril
Anti-intestinal secretion agent indicated for the management of acute diarrhoea in babies, children and adults.
WAKIX - Pitolisant (Film-Coated Tablet)
Antagonist/inverse agonist of the H3 histamine receptor indicated for the treatment of narcolepsy with or without cataplexy in adults.
Model Clastoban - Anhydrous Sodium Clodronate (Film-Coated Tablet)
Oral follow-up treatment of injectable therapy for malignant hypercalcaemia, Palliative treatment of osteolysis of malignant origin with or without hypercalcaemia, in conjunction with specific cancer treatment, In the event of hypercalcaemia, the treatment must be associated with optimal rehydration.
Model Cleviprex - Clevidipine 0.5 Mg/Ml (Emulsion For Injection)
CLEVIPREX is indicated for the rapid reduction of blood pressure in the peri-operative context in adults.
Model Fanolyte - Glucose, Sodium Chloride, Tripotassium Citrate and Citric Acid
Fanolyte is intended to compensate for water and electrolyte losses in the context of acute diarrhoea or gastroenteritis.
Model Helicobacter Test Infai - White Crystalline Powder for Drinkable Solution
Helicobacter Test INFAI can be used for the un vivo diagnosis of gastroduodenal infection with Helicobacter pylori in children past the age of 3 years, adolescents and adults likely to suffer from a peptic ulcer. This medication is for diagnostic use only.
Model Kengrexal - Cangrelor (Powder For Solution To Be Diluted For Injection/Perfusion)
Kengrexal, co-administered with acetylsalicylic acid (ASA), is indicated for the reduction of thrombotic cardiovascular events in adult patients with coronary artery disease having undergone a percutaneous coronary intervention (PCI), who have not received an oral P2Y12 receptor inhibitor prior to the intervention and in whom the oral route for such a treatment is not feasible or desirable.
Model Ozawade - Pitolisant (Film-Coated Tablet)
Ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with Obstructive Sleep Apnoea (OSA) whose sleepiness is not satisfactorily addressed by primary OSA treatment such as Continuous Positive Airway Pressure (CPAP) or in those who do not tolerate this treatment.
Model Remodulin - Treprostinil (Solution For Perfusion)
Treatment of idiopathic or hereditary pulmonary hypertension in view of improving exercise tolerance and disease symptoms in New York Heart Association (NYHA) functional class III patients.